Walgreens Q3 loss per share $0.20, adjusted EPS $0.38; sales up 7.2%; FY guidance withdrawn due to Sycamore deal

Walgreens Boots Alliance, Inc.

2025-Q3 EPS reported -$3.81 revenue$117,034,000,000

Q3 loss per share $0.20 vs EPS $0.40 in year-ago quarter; adjusted EPS $0.38 vs $0.63.
Sales increased 7.2% to $39.0B; constant currency growth 6.9%.
Operating income $53M, down from $111M prior year, including non-cash impairment charge.
Fiscal 2025 guidance withdrawn due to pending acquisition by Sycamore Partners.
CEO Tim Wentworth: cost savings from U.S. Retail Pharmacy partially offset weak U.S. front-end sales.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.